How is postural orthostatic tachycardia syndrome related to thiamine deficiency?

Relationship Between POTS and Thiamine Deficiency

Thiamine deficiency is not recognized as a cause or established pathophysiological mechanism of POTS in current guidelines, though both conditions can independently cause dysautonomia and orthostatic symptoms.

Key Evidence from Guidelines

The 2020 Canadian Cardiovascular Society position statement on POTS 111 comprehensively outlines the pathophysiology of POTS, identifying several mechanisms including:

• Autonomic denervation
• Hypovolemia
• Hyperadrenergic stimulation
• Deconditioning

Notably, thiamine deficiency is not mentioned as a pathophysiological mechanism or associated condition in these authoritative guidelines.

Overlapping Clinical Features

While not causally linked in POTS literature, both conditions share autonomic dysfunction:

Thiamine Deficiency Manifestations

According to the 2022 ESPEN micronutrient guideline 2, thiamine deficiency presents with:

• Neurological symptoms (mental changes, confusion, irritability, cognitive deficits)
• Cardiovascular involvement (beriberi, congestive heart failure)
• Autonomic dysfunction

A case report 3 documented prolonged hypotension and dysautonomia associated with Wernicke's encephalopathy, demonstrating that severe thiamine deficiency can cause autonomic nervous system dysfunction.

POTS Manifestations

POTS presents with 1:

• Excessive orthostatic tachycardia (≥30 bpm increase on standing in adults)
• Orthostatic intolerance symptoms
• Autonomic dysfunction

Clinical Implications

When evaluating a patient with suspected POTS, thiamine deficiency should be considered as a secondary cause of orthostatic symptoms that could mimic or coexist with POTS, rather than as a direct cause of POTS itself.

Screening Recommendations

The Canadian guidelines 11 recommend routine blood work during initial POTS assessment including:

• Complete blood count
• Electrolytes (Na+, K+, Cl-)
• Renal function
• Ferritin
• Thyroid stimulating hormone
• Morning cortisol

Thiamine levels are not included in routine POTS screening protocols.

When to Consider Thiamine Testing

Based on the ESPEN guideline 2, measure thiamine (RBC or whole blood thiamine diphosphate) in patients with:

• Prolonged diuretic treatment with cardiomyopathy
• Prolonged medical nutrition or post-bariatric surgery
• Refeeding syndrome risk
• Encephalopathy
• Chronic alcohol consumption
• Malnutrition or poor oral intake

Treatment Approach

If thiamine deficiency is identified in a patient with orthostatic symptoms:

1. Treat the thiamine deficiency first 2:

   • Mild deficiency: 10 mg/day orally for 1 week, then 3-5 mg daily for ≥6 weeks
   • High suspicion or proven deficiency: 200 mg IV three times daily
   • Maintenance: 50-100 mg/day orally

2. Reassess orthostatic symptoms after thiamine repletion:

   • If symptoms resolve, the diagnosis was likely thiamine-related dysautonomia, not POTS
   • If symptoms persist and meet hemodynamic criteria (sustained ≥30 bpm HR increase on standing with standing HR ≥90 bpm), proceed with POTS diagnosis and treatment 11

Important Caveats

• Do not delay POTS treatment while investigating thiamine status unless there is clear clinical suspicion of deficiency (alcohol abuse, malnutrition, recent bariatric surgery, chronic diuretic use)
• Thiamine deficiency causing dysautonomia would be classified as "postural tachycardia of other cause" (PTOC) in the Canadian framework 11, not primary POTS
• The excessive orthostatic tachycardia in thiamine deficiency should resolve with thiamine replacement, unlike primary POTS which requires ongoing management

In summary: Screen for thiamine deficiency when risk factors are present, but recognize it as a potential mimicker or secondary cause rather than an established mechanism of primary POTS.